Could a 14-Hour nightly fast ward off blood cancer?

NCT ID NCT05565638

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times

Summary

This study tested whether fasting for 14 hours each night helps overweight people with early blood conditions (MGUS or smoldering myeloma) lose weight and lower their risk of developing multiple myeloma. Twenty-three participants were randomly assigned to either the fasting program or a healthy lifestyle education group for 4 months. The goal was to see if this simple dietary change could improve body composition and reduce cancer-related proteins in the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

prolonged nightly fasting (behavioral intervention)

What this could lead to

If it works, this could point toward a simple lifestyle change to reduce the risk of blood cancer in people with early warning signs.

What could go wrong

This is a very small, early study with only 23 participants, so results may not apply to everyone. Fasting for 14 hours nightly may be hard to stick with long-term.

Conditions

The condition(s) this trial relates to.

Fasting plasma cell myeloma Smoldering Multiple Myeloma Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.